APA (7th ed.) Citation

Muzica, C. M., Stanciu, C., Cijevschi-Prelipcean, C., Girleanu, I., Huiban, L., Petrea, O. C., . . . Trifan, A. (2021). Long-Term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection. Hepatitis Monthly, 21(6), 1. https://doi.org/10.5812/hepatmon.115910

Chicago Style (17th ed.) Citation

Muzica, Cristina Maria, et al. "Long-Term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection." Hepatitis Monthly 21, no. 6 (2021): 1. https://doi.org/10.5812/hepatmon.115910.

MLA (9th ed.) Citation

Muzica, Cristina Maria, et al. "Long-Term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection." Hepatitis Monthly, vol. 21, no. 6, 2021, p. 1, https://doi.org/10.5812/hepatmon.115910.